key: cord-0925853-7g2xn42d authors: Brès, Florence; Joyeux, Marie-Alix; Delemer, Brigitte; Vitellius, Géraldine; Barraud, Sara title: Three cases of thyroiditis after COVID-19 RNA-vaccine date: 2022-05-01 journal: Ann Endocrinol (Paris) DOI: 10.1016/j.ando.2022.04.014 sha: 589d9dc336dac4b249074c7e8b99c0fa6a074222 doc_id: 925853 cord_uid: 7g2xn42d nan A 44-year-old female nurse came to our emergency room for severe anterior right neck 50 pain associated with headache. She had no history of thyroid or autoimmune disease. 51 Symptoms appeared 5 weeks after the first dose of Comirnaty vaccine and did not improve 52 despite 6 days' self-medication with non-steroidal anti-inflammatory drugs. Her heart rate was 93 bpm, with 38.3°C fever. Thyroid palpation found global sensitivity, 54 with pain especially on the right side. Thyroid function was normal (TSH: 0.75mIU/L), 55 thyroid antibodies were negative, but CRP level was elevated (21mg/L). Thyroid J o u r n a l P r e -p r o o f patient, a nurse, was professionally obliged to receive the 2nd dose, in spite of the episode 139 of thyroiditis. She did not present any recurrence of symptoms and TSH remained normal. 140 We report 3 cases of thyroiditis following RNA vaccination against Covid-19: two cases of 141 SAT and one conversion from Hashimoto's thyroiditis to Graves' disease years after 142 diagnosis. Two patients received a second dose of vaccine without worsening. SAT 143 symptomatology is not always typical but can be significant and thus may wrongly suggest 144 infectious or neoplastic pathology. It is therefore essential that the medical community be 145 aware of this potential rare side-effect, especially with the need for boosters. Despite the 146 initial symptoms, which were sometimes serious, the final consequences were minimal. Written informed consent was obtained from the patients for publication of these case 158 reports and the accompanying images. There was no need for institutional review board 159 approval, as this was only a case report with a review and did not involve a study protocol. Three Cases of Subacute Thyroiditis Following 169 -2 Vaccine: Post-vaccination ASIA Syndrome COVID-19 vaccine-associated 175 subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for 178 Coronavirus Disease (COVID-19) SARS-CoV-2 vaccine-induced subacute 181 thyroiditis Subacute Thyroiditis following mRNA COVID-19 Vaccine Subacute thyroiditis following COVID-19 187 vaccination in a 67-year-old male patient: a case report Subacute thyroiditis after inactive SARS-CoV-2 vaccine Subacute thyroiditis following COVID-19 vaccination Letter to the Editor: Thyroiditis 194 and Thyrotoxicosis After the SARS-CoV-2 mRNA Vaccine Thyroiditis following vaccination against COVID-19: 197 Report of two cases and review of the literature COVID-19 vaccination and a severe pain in the neck Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based 204 SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis Can COVID-19 immunisation cause 207 subacute thyroiditis? Subacute Thyroiditis After mRNA Vaccine for Covid-19 Significance of HLA Haplotypes in 211 Two Patients with Subacute Thyroiditis Triggered by mRNA-Based COVID-19 Vaccine New aspects in the pathogenesis and management of 214 subacute thyroiditis Graves' disease following SARS-CoV-2 224 vaccination Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An 227 Autoimmune/Inflammatory Syndrome Induced by Adjuvants Two further cases of Graves' disease following SARS-Cov-2 230 vaccination Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple 233 Coincidence? The pathogenesis of thyroid autoimmune diseases New T lymphocytes -Cytokines circuits beyond the Th1-Th2 paradigm Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients